Latest Convertible Note Offer News

Life360 has increased its convertible notes offering to $275 million, introducing capped call transactions to manage dilution risks as it prepares for potential growth investments.

Life360 has announced a $250 million convertible senior notes offering, with an option for an additional $37.5 million, aiming to bolster its balance sheet and support strategic initiatives.

Genmin Limited has signed a non-binding term sheet for a US$3 million convertible notes offer with a prominent US family office, aiming to accelerate development of its Baniaka iron ore project in Gabon.

Ionic Rare Earths has announced a $3 million capital raise via convertible notes, aimed at advancing its rare earth projects across multiple continents. The raise, pending shareholder approval, underscores the company’s strategic push into sustainable rare earth extraction and recycling technologies.

Pilot Energy has locked in a $1.8 million convertible note funding deal led by Discovery Investments, fueling its transition from oil production to carbon storage at the Cliff Head site. The funding hinges on upcoming shareholder approval and replaces a previously stalled arrangement.

MyEco Group has secured $1.6 million through unsecured convertible notes to support a strategic operational restructure aimed at reducing costs and scaling production. This capital raise complements existing cash reserves and aims to improve margins while minimising shareholder dilution.

Tartana Minerals has made significant strides towards boosting copper output by signing a key agreement to process ore at the Mungana facility, securing a $10 million financing package, and winning a government grant for exploration drilling.

FirstWave Cloud Technology reported a mixed Q3 FY25 with declining cash reserves and ARR but secured a strategic AWS-funded partnership to accelerate cloud service adoption.

Osteopore Limited has announced a $20 million convertible notes offering aimed at bolstering its capital for ongoing operations and future projects. The highly speculative offer targets sophisticated investors and underscores the company’s strategic funding approach amid competitive medical device markets.

HALO Technologies reports a robust 45.5% increase in operating revenue for 2024, driven by surging Funds Under Management and brokerage income, while advancing its UK market entry alongside a $6.75 million capital raise.

Imugene Limited has secured A$20 million through convertible notes as part of a broader A$46 million capital raise, aiming to advance its promising immuno-oncology pipeline.

DomaCom Limited reported a steep $4.5 million loss for the half-year ending December 2023, driven by declining revenues and operational hurdles, including a temporary suspension of its fund's Product Disclosure Statement. The company is actively pursuing capital raises to stabilize its position.